Calliditas Therapeutics
CALT
#5402
Rank
ยฃ0.86 B
Marketcap
ยฃ31.39
Share price
-0.10%
Change (1 day)
143.09%
Change (1 year)

Revenue for Calliditas Therapeutics (CALT)

Revenue in 2024 (TTM): ยฃ0.12 Billion

According to Calliditas Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ0.11 Billion. In 2023 the company made a revenue of ยฃ90.35 Million an increase over the revenue in the year 2022 that were of ยฃ63.03 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Calliditas Therapeutics from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.12 B34.04%
2023 ยฃ90.35 M43.32%
2022 ยฃ63.03 M227.5%
2021 ยฃ19.24 M27196.34%
2020 ยฃ0.07 M-99.53%
2019 ยฃ15.14 M
2018 N/A
2017 N/A